Methycobal | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Tablet: Adverse reactions were reported in 146 of 15,180 patients (0.96%): Gastrointestinal: >5%, ≥0.1%: Anorexia, nausea/vomiting and diarrhea.
Hypersensitivity: <0.1%: Rash. In the event of such symptoms, treatment should be discontinued.
Ampoule: Hypersensitivity: Use of Methycobal should be discontinued if symptoms of hypersensitivity eg, skin eruptions, occur.
Others: Pain and induration may infrequently occur at the site of IM injection and headache, sweating or hot sensation may rarely occur.

View ADR Reporting Link

Methycobal Adverse Reactions

mecobalamin

Manufacturer:

Eisai

Distributor:

DKSH